Characteristics of mothers | Telbivudine group (N = 139) | Control group (N = 102) | P value |
---|---|---|---|
Age, years, median (range) | 26 (20–43) | 26 (18–42) | 0.061 |
Prior pregnancy, median (range) | 1 (1–4) | 1 (1–4) | 0.224 |
HBV DNA levels, log10 IU/mL, median (range) | 7.73 (6.04~9.30) | 7.72 (6.03~9.00) | 0.858 |
HBV DNA levels > 108 IU/mL, n (%) | 60 (43.2%) | 45 (44.1%) | 0.883 |
HBV DNA levels 107–108 IU/mL, n (%) | 62 (44.6%) | 36 (35.3%) | 0.184 |
ALT level, U/L, median (range) | 117 (56–1166) | 164 (53–1025) | 0.867 |
AST level, U/L, median (range) | 112 (32–1061) | 101 (35–539) | 0.301 |
Elevated AST levels, n (%) | 136 (97.8%) | 101 (99.0%) | 0.640 |
TBIL, μmol/L, median (range) | 11 (4–125) | 11 (3–96) | 0.911 |
HBeAg positive, n (%) | 126 (90.6%) | 91 (89.2%) | 0.714 |